Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis.
about
Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Clinical outcomes of transcath ...... acute portal vein thrombosis.
@en
Clinical outcomes of transcath ...... acute portal vein thrombosis.
@nl
type
label
Clinical outcomes of transcath ...... acute portal vein thrombosis.
@en
Clinical outcomes of transcath ...... acute portal vein thrombosis.
@nl
prefLabel
Clinical outcomes of transcath ...... acute portal vein thrombosis.
@en
Clinical outcomes of transcath ...... acute portal vein thrombosis.
@nl
P2093
P2860
P356
P1476
Clinical outcomes of transcath ...... acute portal vein thrombosis.
@en
P2093
Jian-Ming Sun
Ting-Ting Jiang
Xiao-Ping Luo
P2860
P304
P356
10.3748/WJG.V23.I41.7470
P407
P577
2017-11-01T00:00:00Z